[Chronic myeloid leukemia. New prospects for marrow autotransplantation].
Carella
A M
AM
Terapia Intensiva Oncoematologia, Ospedale S. Martino, Genova.
Carlier
P
P
Nati
S
S
Congiu
A
A
Pierluigi
D
D
Raffo
M R
MR
D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor; D001752:Blast Crisis / Q000601:surgery; D016465:Bone Marrow Purging; D016026:Bone Marrow Transplantation; D002999:Clone Cells / Q000473:pathology; D003131:Combined Modality Therapy; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D016898:Interferon-alpha / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000401:mortality / Q000473:pathology / Q000601:surgery* / Q000628:therapy; D015466:Leukemia, Myeloid, Chronic-Phase / Q000601:surgery; D014411:Neoplastic Stem Cells / Q000473:pathology; D010677:Philadelphia Chromosome; D012074:Remission Induction; D014182:Transplantation, Autologous
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D007155:Immunologic Factors; D016898:Interferon-alpha
La leucemia mieloide cronica. Nuove prospettive con l'autotrapianto di midollo.